Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Current evidence for monitoring platelet reactivity in acute coronary syndrome: a plea for individualized antiplatelet treatment.

Aradi D, Sibbing D, Bonello L.

Int J Cardiol. 2013 Sep 1;167(5):1794-7. doi: 10.1016/j.ijcard.2012.12.026. Epub 2013 Jan 3. Review.

PMID:
23290951
2.

A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients.

Straub N, Beivers A, Lenk E, Aradi D, Sibbing D.

Thromb Haemost. 2014 Feb;111(2):290-9. doi: 10.1160/TH13-08-0679. Epub 2013 Oct 24.

PMID:
24154566
3.
4.

Current Status of Antiplatelet Therapy in Acute Coronary Syndrome.

Dash D.

Cardiovasc Hematol Agents Med Chem. 2015;13(1):40-9. Review.

PMID:
26245659
5.

Evolving role of platelet function testing in coronary artery interventions.

Sharma RK, Voelker DJ, Sharma R, Reddy HK, Dod H, Marsh JD.

Vasc Health Risk Manag. 2012;8:65-75. doi: 10.2147/VHRM.S28090. Epub 2012 Feb 8. Review.

6.

Response variability to P2Y12 receptor inhibitors: expectations and reality.

Siller-Matula JM, Trenk D, Schrör K, Gawaz M, Kristensen SD, Storey RF, Huber K; EPA (European Platelet Academy).

JACC Cardiovasc Interv. 2013 Nov;6(11):1111-28. doi: 10.1016/j.jcin.2013.06.011. Review.

7.

New antiplatelet agents and the role of platelet function testing in acute coronary syndromes.

Sinhal AR, Aylward PE.

Clin Ther. 2013 Aug;35(8):1064-8. doi: 10.1016/j.clinthera.2013.07.429. Review.

PMID:
23973039
8.

Potent P2Y12 receptor inhibitors in patients with acute coronary syndrome. Agents, indications, issues to consider in clinical practice.

Sibbing D, Orban M, Massberg S.

Hamostaseologie. 2013;33(1):9-15. doi: 10.5482/HAMO-12-12-0022. Epub 2013 Jan 8. Review.

PMID:
23299202
9.

Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.

Mousa SA, Jeske WP, Fareed J.

Clin Appl Thromb Hemost. 2010 Apr;16(2):170-6. doi: 10.1177/1076029609355589. Review.

PMID:
20299391
10.

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.

Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, Kirtane A, Siller-Matula J, Mahla E, Becker RC, Bhatt DL, Waksman R, Rao SV, Alexopoulos D, Marcucci R, Reny JL, Trenk D, Sibbing D, Gurbel PA; Working Group on On-Treatment Platelet Reactivity.

J Am Coll Cardiol. 2013 Dec 17;62(24):2261-73. doi: 10.1016/j.jacc.2013.07.101. Epub 2013 Sep 27.

11.

Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study.

Alexopoulos D, Galati A, Xanthopoulou I, Mavronasiou E, Kassimis G, Theodoropoulos KC, Makris G, Damelou A, Tsigkas G, Hahalis G, Davlouros P.

J Am Coll Cardiol. 2012 Jul 17;60(3):193-9. doi: 10.1016/j.jacc.2012.03.050.

12.

Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?

Kowalczyk M, Banach M, Mikhailidis DP, Hannam S, Rysz J.

Med Sci Monit. 2009 Dec;15(12):MS24-30. Review.

PMID:
19946242
13.

Platelet hyperreactivity and stent thrombosis in patients undergoing coronary stenting.

Mayer K, Sibbing D.

Curr Vasc Pharmacol. 2012 Sep;10(5):597-605. Review.

PMID:
22338575
14.

Platelet function testing in patients with acute coronary syndrome.

Orban M, Sibbing D.

J Cardiovasc Transl Res. 2013 Jun;6(3):371-7. doi: 10.1007/s12265-013-9450-7. Epub 2013 Feb 9. Review.

PMID:
23397280
15.

Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome.

Tan GM, Lam YY, Yan BP.

Cardiovasc Ther. 2012 Aug;30(4):e167-73. doi: 10.1111/j.1755-5922.2011.00262.x. Epub 2011 Jul 31. Review.

PMID:
21883998
16.

[Antiplatelet therapy in acute coronary syndromes: state of the art and new perspectives].

Riva L, Di Pasquale G, Casella G, Calabrese D, Zagnoni S, Pallotti MG.

G Ital Cardiol (Rome). 2010 Dec;11(12 Suppl 3):27S-33S. Italian.

PMID:
21491737
17.

Clinical use of clopidogrel.

Sarafoff N, Byrne RA, Sibbing D.

Curr Pharm Des. 2012;18(33):5224-39. Review.

PMID:
22724411
18.

Tailoring antiplatelet therapy: a step toward individualized therapy to improve clinical outcome?

Laine M, Camoin-Jau L, Bessereau J, Sébastien A, Paganelli F, Bonello L.

Curr Pharm Des. 2012;18(33):5392-401. Review.

PMID:
22724420
19.

[Extent of platelet aggregation inhibition and clinical events: new evidence with prasugrel].

Abbate R, Crea F, De Servi S, Filippi E, Gensini GF, Golinos P, Savonitto S.

G Ital Cardiol (Rome). 2010 Feb;11(2):127-37. Review. Italian.

PMID:
20408476
20.

Platelet function monitoring in patients on clopidogrel: What should we learn from GRAVITAS?

Aradi D, Komócsi A.

Platelets. 2012;23(3):167-76. doi: 10.3109/09537104.2011.610475. Epub 2011 Sep 30. Review.

PMID:
21958190
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk